Palisade Bio, Inc.
Palisade Bio, Inc. (PALI) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · PALI · as of Jun 9, 2026
Activity summary
Buy transactions
2
P-Purchase only
Sell transactions
2
12 Months
Buy/Sell ratio
1.00
Buy/Sell (by trades)
Overall sentiment
Palisade Bio, Inc. insiders have shown mixed buying and selling activity over the past 12 Months.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
PALI insider buying and selling by quarter
PALI insider selling · PALI insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · PALI ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
PALI executive sell shares · PALI board member insider trading · PALI insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Feb 11, 2026 | Jones Mitchell Lawrence Chief Medical Officer | Option | 8,000 | — | Form 4 |
| Feb 12, 2026 | Jones Mitchell Lawrence Chief Medical Officer | Sale | 1,989 | $3K | Form 4 |
| Feb 11, 2026 | Finley John David CEO, CFO · Director | Option | 13,333 | — | Form 4 |
| Feb 12, 2026 | Finley John David CEO, CFO · Director | Sale | 3,896 | $7K | Form 4 |
| Jan 16, 2026 | Williams Donald Allen Director | Purchase | 5,000 | $8K | Form 4 |
| Jan 9, 2026 | Williams Donald Allen Director | Purchase | 5,000 | $9K | Form 4 |
Jones Mitchell Lawrence
Chief Medical Officer
Date
Feb 11
Shares
8,000
Price
—
Value
—
Jones Mitchell Lawrence
Chief Medical Officer
Date
Feb 12
Shares
1,989
Price
$1.75
Value
$3K
Finley John David
CEO, CFO · Director
Date
Feb 12
Shares
3,896
Price
$1.75
Value
$7K
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About PALI insider trading
PALI insider trades
Palisade Bio, Inc. (PALI) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Jones Mitchell Lawrence (Chief Medical Officer), Finley John David (CEO, CFO · Director), Williams Donald Allen (Director). Over the past 12 months, 3 insiders have filed transactions with the SEC. PALI insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Palisade Bio, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
PALI insider trading · 5 questionsThe insiders of Palisade Bio, Inc. (PALI) include executives and directors such as Jones Mitchell Lawrence (Chief Medical Officer), Finley John David (CEO, CFO · Director), Williams Donald Allen (Director), among others. Over the past 12 months, 3 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026